AXIM Biotechnologies, Inc.
AXIM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $156 | $47 | $453 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $57 | $184 |
| Total Curr. Assets | $1 | $156 | $104 | $637 |
| Property Plant & Equip (Net) | $237 | $361 | $114 | $194 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3,201 | $3,595 | $3,989 | $4,384 |
| Long-Term Investments | $0 | $0 | $46 | $104 |
| Tax Assets | $0 | $0 | -$46 | -$104 |
| Other NC Assets | $9 | $9 | $5 | $109 |
| Total NC Assets | $3,447 | $3,965 | $4,108 | $4,687 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,447 | $4,122 | $4,212 | $5,323 |
| Liabilities | – | – | – | – |
| Payables | $1,786 | $2,781 | $1,316 | $816 |
| Short-Term Debt | $77 | $95 | $20 | $1,671 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $233 | $303 | $333 | $0 |
| Other Curr. Liab. | $4,666 | $2,799 | $1,723 | $93 |
| Total Curr. Liab. | $6,762 | $5,978 | $3,392 | $2,581 |
| LT Debt | $6,563 | $5,800 | $5,645 | $5,081 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $541 | $0 | $0 | $0 |
| Total NC Liab. | $7,104 | $5,800 | $5,645 | $5,081 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $63 | $232 | $20 | $77 |
| Total Liabilities | $13,867 | $11,778 | $9,037 | $7,662 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $32 | $25 | $19 | $14 |
| Retained Earnings | -$75,697 | -$72,185 | -$64,125 | -$57,882 |
| AOCI | $0 | $0 | $89 | $4,530 |
| Other Equity | $65,246 | $64,504 | $59,191 | $51,000 |
| Total Equity | -$10,420 | -$7,657 | -$4,825 | -$2,338 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,447 | $4,122 | $4,212 | $5,323 |
| Net Debt | $6,640 | $5,738 | $5,617 | $6,299 |